NIVF
NewGenIvf Group Limited Class A Ordinary Shares
NASDAQ: NIVF · HEALTHCARE · MEDICAL CARE FACILITIES
$1.72
-6.01% today
Updated 2026-04-30
Market cap
$1.11M
P/E ratio
0.05
P/S ratio
0.24x
EPS (TTM)
$36.48
Dividend yield
—
52W range
$2 – $1,488
Volume
0.3M
NewGenIvf Group Limited Class A Ordinary Shares (NIVF) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $4.12M | $5.94M | $5.14M | $5.43M | $4.73M |
| Revenue growth (YoY) | — | +44.3% | -13.6% | +5.8% | -13.0% |
| Cost of revenue | $3.09M | $4.41M | $3.45M | $3.61M | $3.77M |
| Gross profit | $1.02M | $1.54M | $1.68M | $1.83M | $955846.00 |
| Gross margin | 24.9% | 25.9% | 32.7% | 33.6% | 20.2% |
| R&D | — | — | — | — | — |
| SG&A | $801329.00 | $1.10M | $1.62M | $2.78M | $10.49M |
| Operating income | $198758.00 | $-504907.00 | $-2.52M | $-1.16M | $-10.73M |
| Operating margin | 4.8% | -8.5% | -49.1% | -21.4% | -226.9% |
| EBITDA | $587012.00 | $725689.00 | $-2.52M | $24264.00 | $10.84M |
| EBITDA margin | 14.3% | 12.2% | -49.1% | 0.4% | 229.4% |
| EBIT | $244473.00 | $421745.00 | $-2.75M | $-182000.00 | $10.35M |
| Interest expense | $88289.00 | $77757.00 | $46179.00 | $778656.00 | $616423.00 |
| Income tax | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-533.00 | $458667.00 | $-690851.00 | $-525000.00 | $9.88M |
| Net income growth (YoY) | — | +86153.8% | -250.6% | +24.0% | +1981.8% |
| Profit margin | -0.0% | 7.7% | -13.5% | -9.7% | 209.0% |